Looks like you’re on the US site. Choose another location to see content specific to your location

Home Medical Devices US Johnson & Johnson’s Groundbreaking Kincise System Revolutionizes Knee and Hip Surgeries
surgical tools

Johnson & Johnson’s Groundbreaking Kincise System Revolutionizes Knee and Hip Surgeries

3rd June 2025

Johnson & Johnson has announced the launch of the Kincise 2 System, a pioneering automated surgical impactor specifically designed for knee and hip revision procedures. As the first device of its kind to receive approval, this system aims to enhance precision and efficiency in orthopedic surgeries. This innovation marks a significant advancement in surgical technology and is expected to improve patient outcomes and streamline procedures, potentially transforming the orthopedic field.

The introduction of the Kincise 2 System represents a leap forward in surgical device technology. Johnson & Johnson, a leader in healthcare innovation, has focused on developing this tool to support orthopedic surgeons in the demanding field of joint revisions. Traditionally, knee and hip revision surgeries require manual impactors, which can be challenging and time-consuming. The Kincise 2 System automates this process, promising enhanced surgical precision and reduced operative time. With the increasing demand for joint replacement surgeries due to an aging population, this advancement is timely. This new system underscores Johnson & Johnson’s commitment to advancing healthcare technology and improving both surgeon experience and patient care.

In summary, Johnson & Johnson’s launch of the Kincise 2 System marks a transformative moment for orthopedic surgeries. By automating a critical procedure step, it not only streamlines operations but also stands to significantly enhance patient outcomes. This innovation exemplifies the ongoing strides in medical technology aimed at meeting the growing healthcare needs worldwide.

For the latest updates and in-depth insights into the world of Medical Devices, including breakthrough treatments, industry trends, and regulatory news, contact Steffan Mortimer today!

Stay informed

Receive the latest industry news, Tips and straight to your inbox.